Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

por Yao, Chih-Chien, Hung, Chao-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Hung, Lee, Chung-Mo, Chen, Chien-Hung
Publicado 2017